Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eliezer Rachmilewitz

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|September 16, 2005
Beta-thalassemiaDeborah Rund, Eliezer Rachmilewitz
Current Molecular Medicine|November 11, 2008
The role of oxidative stress in hemolytic anemiaEitan Fibach, Eliezer Rachmilewitz
Expert Review of Hematology|February 23, 2010
Future alternative therapies for β-thalassemiaStefano Rivella, Eliezer Rachmilewitz
Mediterranean Journal of Hematology and Infectious Diseases|March 29, 2014
The Price of Mercy: Comment to the Paper Entitled "Prevention of Beta Thalassemia In Northern Israel - A Cost-Benefit Analysis" by Koren et Al. recently published in Mediterranean Journal of Hematology and Infectious DiseasesPiero C Giordano, Eliezer Rachmilewitz
Critical Reviews in Oncology/Hematology|April 22, 2017
Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignanciesHeather A Leitch, Eitan Fibach, Eliezer Rachmilewitz
Current Molecular Medicine|November 11, 2008
HemoglobinopathiesElliott Vichinsky, Griffin P Rodgers, Eliezer Rachmilewitz
The American Journal of Medicine|May 4, 2005
Age-adjusted survival gained by treatment: an alternative way of presenting survivalAbraham Klepfish, Eliezer Rachmilewitz, Miriam Sarid, et al.
British Journal of Haematology|April 19, 2011
Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromesSylvia T Singer, Elliott P Vichinsky, Nancy Sweeters, et al.
Blood|June 14, 2014
Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndromeNiraj Shenoy, Nishanth Vallumsetla, Eliezer Rachmilewitz, et al.
European Journal of Haematology|November 3, 2007
Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndromeHussam Ghoti, Johnny Amer, Asher Winder, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|September 16, 2005
Beta-thalassemiaDeborah Rund, Eliezer Rachmilewitz
Current Molecular Medicine|November 11, 2008
The role of oxidative stress in hemolytic anemiaEitan Fibach, Eliezer Rachmilewitz
Expert Review of Hematology|February 23, 2010
Future alternative therapies for β-thalassemiaStefano Rivella, Eliezer Rachmilewitz
Mediterranean Journal of Hematology and Infectious Diseases|March 29, 2014
The Price of Mercy: Comment to the Paper Entitled "Prevention of Beta Thalassemia In Northern Israel - A Cost-Benefit Analysis" by Koren et Al. recently published in Mediterranean Journal of Hematology and Infectious DiseasesPiero C Giordano, Eliezer Rachmilewitz
Critical Reviews in Oncology/Hematology|April 22, 2017
Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignanciesHeather A Leitch, Eitan Fibach, Eliezer Rachmilewitz
Current Molecular Medicine|November 11, 2008
HemoglobinopathiesElliott Vichinsky, Griffin P Rodgers, Eliezer Rachmilewitz
The American Journal of Medicine|May 4, 2005
Age-adjusted survival gained by treatment: an alternative way of presenting survivalAbraham Klepfish, Eliezer Rachmilewitz, Miriam Sarid, et al.
British Journal of Haematology|April 19, 2011
Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromesSylvia T Singer, Elliott P Vichinsky, Nancy Sweeters, et al.
Blood|June 14, 2014
Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndromeNiraj Shenoy, Nishanth Vallumsetla, Eliezer Rachmilewitz, et al.
European Journal of Haematology|November 3, 2007
Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndromeHussam Ghoti, Johnny Amer, Asher Winder, et al.
Pageof 3